Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: filgrastim|BIOLOGICAL: pegfilgrastim|DRUG: lyso-thermosensitive liposomal doxorubicin(Thermodox)|PROCEDURE: hyperthermia treatment
Sponsor: Duke University
Collaborators: National Cancer Institute (NCI)